A clinically studied GLP-1 pathway treatment for appetite control and metabolic health
Epitalon's Regulatory History Epitalon's journey through the US regulatory system has been challenging: International use: Epitalon has been studied and used clinically in Russia and other countries for years, with a substantial body of published research spanning animal and human studies
Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives
Scientific and Official Sources PubChem: BPC-157 sequence-related identity, molecular formula and calculated molecular weight United States FDA: 2026 briefing document for BPC-157 free peptide and BPC-157 acetate ClinicalTrials.gov: BPC-157 safety and pharmacokinetics Phase I registry record Sikiric and colleagues: BPC-157, L-arginine and nitric-oxide-system research Lojo and colleagues: experimental use of BPC-157, L-NAME and L-arginine as separate agents McGuire and colleagues: review of BPC-157 evidence and safety uncertainties United States FDA: safety concerns involving certain bulk substances, including BPC-157 MHRA: borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 World Anti-Doping Agency: 2026 Prohibited List
First and foremost, these injections can lift your metabolism, which makes it easier for your body to burn fat
Unlike other companies that are just trying to sell you their stuff with clickbait and fake news, we make sure theres a research study to backup everything we say
